Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation

被引:79
|
作者
Bodenmann, S. [1 ]
Hohoff, C. [2 ]
Freitag, C. [3 ]
Deckert, J. [2 ,4 ]
Retey, J. V. [1 ]
Bachmann, V. [1 ,5 ]
Landolt, H-P [1 ,5 ]
机构
[1] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland
[2] Univ Munster, Dept Psychiat, Munster, Germany
[3] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, Frankfurt, Germany
[4] Univ Wurzburg, Dept Psychiat, D-8700 Wurzburg, Germany
[5] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
adenosine; sleep homeostasis; vigilance; stimulant; pharmacogenetics; modafinil; ADENOSINE A(2A) RECEPTORS; INTERINDIVIDUAL DIFFERENCES; GENETIC-VARIATION; INDUCED ANXIETY; PANIC DISORDER; BASAL GANGLIA; REACTION-TIME; ASSOCIATION; HOMEOSTASIS; HUMANS;
D O I
10.1111/j.1476-5381.2011.01689.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND AND PURPOSE Prolonged wakefulness impairs sustained vigilant attention, measured with the psychomotor vigilance task (PVT), and induces a compensatory increase in sleep intensity in recovery sleep, quantified by slow-wave activity (SWA) in the sleep electroencephalogram (EEG). These effects of sleep deprivation are counteracted by the adenosine receptor antagonist caffeine, implying involvement of the adenosine neuromodulator/receptor system. To examine a role for adenosine A(2A) receptors, we investigated whether variation of the A(2A) receptor gene (ADORA2A) modified effects of caffeine on PVT and SWA after sleep deprivation. EXPERIMENTAL APPROACH A haplotype analysis of eight single-nucleotide polymorphisms of ADORA2A was performed in 82 volunteers. In 45 young men carrying five different allele combinations, we investigated the effects of prolonged waking and 2 x 200 mg caffeine or 2 x 100 mg modafinil on psychomotor vigilance, sleepiness, and the waking and sleep EEG. KEY RESULTS Throughout extended wakefulness, the carriers of haplotype HT4 performed faster on the PVT than carriers of non-HT4 haplotype alleles. In haplotype HT4, caffeine failed to counteract the waking-induced impairment of PVT performance and the rebound of SWA in recovery sleep. However, caffeine was effective in non-HT4 allele carriers, and modafinil reduced the consequences of prolonged waking, independently of ADORA2A haplotype. CONCLUSIONS AND IMPLICATIONS Common genetic variation of ADORA2A is an important determinant of psychomotor vigilance in rested and sleep-deprived state. It also modulates individual responses to caffeine after sleep deprivation. These findings demonstrate a role for adenosine A(2A) receptors in the effects of prolonged wakefulness on vigilant attention and the sleep EEG.
引用
下载
收藏
页码:1904 / 1913
页数:10
相关论文
共 50 条
  • [1] The Impact of Genetic Variations in ADORA2A in the Association between Caffeine Consumption and Sleep
    Erblang, Megane
    Drogou, Catherine
    Gomez-Merino, Danielle
    Metlaine, Arnaud
    Boland, Anne
    Deleuze, Jean Francois
    Thomas, Claire
    Sauvet, Fabien
    Chennaoui, Mounir
    GENES, 2019, 10 (12)
  • [2] PER3 and ADORA2A polymorphisms impact neurobehavioral performance during sleep restriction
    Rupp, Tracy L.
    Wesensten, Nancy J.
    Newman, Rachel
    Balkin, Thomas J.
    JOURNAL OF SLEEP RESEARCH, 2013, 22 (02) : 160 - 165
  • [3] Genetics and Cognitive Vulnerability to Sleep Deprivation in Healthy Subjects: Interaction of ADORA2A, TNF-α and COMT Polymorphisms
    Erblang, Megane
    Drogou, Catherine
    Gomez-Merino, Danielle
    Rabat, Arnaud
    Guillard, Mathias
    Beers, Pascal Van
    Quiquempoix, Michael
    Boland, Anne
    Deleuze, Jean Francois
    Olaso, Robert
    Derbois, Celine
    Prost, Maxime
    Dorey, Rodolphe
    Leger, Damien
    Thomas, Claire
    Chennaoui, Mounir
    Sauvet, Fabien
    LIFE-BASEL, 2021, 11 (10):
  • [4] Topographic electroencephalogram changes associated with psychomotor vigilance task performance after sleep deprivation
    Gorgoni, Maurizio
    Ferlazzo, Fabio
    Ferrara, Michele
    Moroni, Fabio
    D'Atri, Aurora
    Fanelli, Stefania
    Torriglia, Isabella Gizzi
    Lauri, Giulia
    Marzano, Cristina
    Rossini, Paolo Maria
    De Gennaro, Luigi
    SLEEP MEDICINE, 2014, 15 (09) : 1132 - 1139
  • [5] Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption
    Peter J Rogers
    Christa Hohoff
    Susan V Heatherley
    Emma L Mullings
    Peter J Maxfield
    Richard P Evershed
    Jürgen Deckert
    David J Nutt
    Neuropsychopharmacology, 2010, 35 : 1973 - 1983
  • [6] Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption
    Rogers, Peter J.
    Hohoff, Christa
    Heatherley, Susan V.
    Mullings, Emma L.
    Maxfield, Peter J.
    Evershed, Richard P.
    Deckert, Juergen
    Nutt, David J.
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (09) : 1973 - 1983
  • [7] Comparison of the effects of 24-hours of total sleep deprivation and sleep interruption on vigilance performance in the rat-psychomotor vigilance task
    Christie, M.
    Conelly, N.
    Bolortuya, Y.
    McCarley, R.
    Strecker, R.
    SLEEP, 2008, 31 : A370 - A370
  • [8] PSYCHOMOTOR VIGILANCE TASK PERFORMANCE DURING SLEEP DEPRIVATION IN TWINS: EVIDENCE FOR HERITABILITY OF SLEEP HOMEOSTASIS
    Kuna, S. T.
    Maislin, G.
    Pack, F. M.
    Staley, B.
    Hachadoorian, R.
    Herman, S.
    Pack, A., I
    SLEEP, 2009, 32 : A129 - A129
  • [9] EFFECTS OF SLEEP DEPRIVATION ON FUNCTIONAL CONNECTIVITY DURING A PSYCHOMOTOR VIGILANCE TASK
    Nguyen, A.
    Cross, N.
    Pomares, F. B.
    Jegou, A.
    Perrault, A. A.
    Lee, K.
    Smith, D.
    Aydin, U.
    Grova, C.
    Dang-Vu, T. T.
    SLEEP MEDICINE, 2019, 64 : S83 - S83
  • [10] A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep
    Retey, J. V.
    Adam, M.
    Khatami, R.
    Luhmann, U. F. O.
    Jung, H. H.
    Berger, W.
    Landolt, H-P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 692 - 698